Successful treatment of cutaneous infection due to Purpureocillium lilacinum using voriconazole
Rika Suzuki
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorCorresponding Author
Yukiko Kiniwa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Correspondence: Yukiko Kiniwa, M.D., Ph.D., Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Email: [email protected]
Search for more papers by this authorTakushi Shirai
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuko Takazawa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorTatsuya Natori
Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan
Search for more papers by this authorTakashi Mochizuki
Department of Dermatology, Kanazawa Medical University, Kanazawa, Japan
Search for more papers by this authorRyuhei Okuyama
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorRika Suzuki
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorCorresponding Author
Yukiko Kiniwa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Correspondence: Yukiko Kiniwa, M.D., Ph.D., Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Email: [email protected]
Search for more papers by this authorTakushi Shirai
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuko Takazawa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorTatsuya Natori
Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan
Search for more papers by this authorTakashi Mochizuki
Department of Dermatology, Kanazawa Medical University, Kanazawa, Japan
Search for more papers by this authorRyuhei Okuyama
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this author
REFERENCES
- 1Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006; 12: 948–960.
- 2Saghrouni F, Saidi W, Ben Said Z et al. Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review. Med Mycol 2013; 51: 664–668.
- 3Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Utton DA, Iwan PC. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008; 10: 117–122.
- 4Demitsu T, Nagashima K, Okabe T et al. Subcutaneous hyalohyphomycosis due to Purpureocillium lilacinum in an immunocompromised patient after renal transplantation. J Dermatol 2017; 44: 725–726.
- 5Castelli MV, Alastruey-Izquierdo A, Cuesta I et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008; 52: 2926–2928.
Citing Literature
